From bench to bedside: how dynamic hollow-fibre in vitro infection experiments and mathematical modelling can inform pharmacokinetic/pharmacodynamic targets for teicoplanin
From bench to bedside: how dynamic hollow-fibre in vitro infection experiments and mathematical modelling can inform pharmacokinetic/pharmacodynamic targets for teicoplanin. // Clinical Microbiology and Infection. – URL: https://www.sciencedirect.com/science/article/pii/S1198743X26003356?dgcid=rss_sd_all
From bench to bedside: how dynamic hollow-fibre in vitro infection experiments and mathematical modelling can inform pharmacokinetic/pharmacodynamic targets for teicoplanin. Clinical Microbiology and Infection. https://www.sciencedirect.com/science/article/pii/S1198743X26003356?dgcid=rss_sd_all
“From bench to bedside: how dynamic hollow-fibre in vitro infection experiments and mathematical modelling can inform pharmacokinetic/pharmacodynamic targets for teicoplanin.” Clinical Microbiology and Infection.
@article{article41169,
title = {From bench to bedside: how dynamic hollow-fibre in vitro infection experiments and mathematical modelling can inform pharmacokinetic/pharmacodynamic targets for teicoplanin},
journal = {Clinical Microbiology and Infection},
url = {https://www.sciencedirect.com/science/article/pii/S1198743X26003356?dgcid=rss_sd_all}
}
ABSTRACT Background Aspergillus fumigatus can cause life‐threatening infections, primarily treated with azole antifungals. Azole‐resistant A. fumigatus (ARAF) is a major clinical concern. Environmental resistance development is an...
ABSTRACT Background The lipid‐dependent yeast genus Malassezia is composed of skin commensals that can become pathogenic. This genus can cause bloodstream infection in low‐weight preterm neonates and immunocompromised adults. However,...